Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans

Hypertension

Volumn 55, Issue 3, 2010, Pages 674-680

  Bellien, Jeremy ^a   Favre, Julie ^a   Iacob, Michele ^a   Gao, Ji ^a   Thuillez, Christian ^a   Richard, Vincent ^a   Joannidès, Robinson ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Arterial stiffness; Cytochrome epoxygenases; Endothelium; Endothelium derived hyperpolarizing factor; NO

Indexed keywords

ACETYLCHOLINE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; FLUCONAZOLE; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; N G MONOMETHYL L ARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTERY DILATATION; ARTERY TONE; ARTICLE; BLOOD FLOW; CONDUCTANCE; CONTROLLED STUDY; CORONARY ARTERY; HEATING; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RADIAL ARTERY; SHEAR STRESS; YOUNG MODULUS;

ADULT; ANIMALS; BENZIMIDAZOLES; BIOLOGICAL FACTORS; BLOOD PRESSURE; ELASTICITY; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FLUCONAZOLE; HOT TEMPERATURE; HUMANS; HYPERTENSION; INDOLES; MALE; MICE; MICE, INBRED STRAINS; NITRIC OXIDE; OMEGA-N-METHYLARGININE; OXIMES; POTASSIUM CHANNEL BLOCKERS; RADIAL ARTERY; REGIONAL BLOOD FLOW; TETRAETHYLAMMONIUM; VASODILATION; YOUNG ADULT;

EID: 77149137396     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.142190     Document Type: Article

References (28)

1. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries: Theoretic, Experimental and Clinical Principles. V ed. London, United Kingdom: Edward Arnold; 2005.
2. Safar ME, O'Rourke ME. Handbook of Hypertension, Arterial Stiffness in Hypertension. Amsterdam, The Netherlands: Elsevier; 2006.
3. Dobrin PB, Roveck AA. Influence of vascular smooth muscle on contractile mechanics and elasticity of arteries. Am J Physiol. 1969;217: 1644-1651.
4. Bank AJ, Wilson RF, Kubo SH, Holte JE, Dresing TJ, Wang H. Direct effects of smooth muscle relaxation and contraction on in vivo human brachial artery elastic properties. Circ Res. 1995;77:1008-1016.
5. Safar M, Chamiot-Clerc P, Dagher G, Renaud JF. Pulse pressure, endo-thelium function, and arterial stiffness in spontaneously hypertensive rats. Hypertension. 2001;38:1416-1421.
6. Joannides R, Costentin A, Iacob M, Bakkali el-H, Richard MO, Thuillez C. Role of arterial smooth muscle tone and geometry in the regulation of peripheral conduit artery mechanics by shear stress. Clin Exp Pharmacol Physiol. 2001;28:1025-1031.
7. Munir S, Jiang B, Guilcher A, Brett S, Redwood S, Marber M, Chow-ienczyk P. Exercise reduces arterial pressure augmentation through vaso-dilation of muscular arteries in humans. Am J Physiol Heart Circ Physiol. 2008;294:H1645-H1650.
8. Sharman JE, McEniery CM, Campbell R, Pusalkar P, Wilkinson IB, Coombes JS, Cockcroft JR. Nitric oxide does not significantly contribute to changes in pulse pressure amplification during light aerobic exercise. Hypertension. 2008;51:856-861.
9. Stewart AD, Millasseau SC, Kearney MT, Ritter JM, Chowienczyk PJ. Effects of inhibition of basal nitric oxide synthesis on carotid-femoral pulse wave velocity and augmentation index in humans. Hypertension. 2003;42:915-918.
10. Wilkinson IB, MacCallum H, Cockcroft JR, Webb DJ. Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol. 2002;53:189-192.
11. Kinlay S, Creager MA, Fukumoto M, Hikita H, Fang JC, Selwyn AP, Ganz P. Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension. 2001;38:1049-1053.
12. Schmitt M, Avolio A, Qasem A, McEniery CM, Butlin M, Wilkinson IB, Cockcroft JR. Basal NO locally modulates human iliac artery function in vivo. Hypertension. 2005;46:227-231.
13. Feletou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol. 2006;26:1215-1225.
14. Bellien J, Thuillez C, Joannides R. Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans. Fundam Clin Pharmacol. 2008;22:363-377.
15. Bellien J, Joannides R, Iacob M, Arnaud P, Thuillez C. Calcium-activated potassium channels and nitric oxide regulate human peripheral conduit artery mechanics. Hypertension. 2005;46:210-216.
16. Bellien J, Iacob M, Gutierrez L, Isabelle M, Lahary A, Thuillez C, Joannides R. Crucial role of NO and endothelium-derived hyperpo-larizing factor in human sustained conduit artery flow-mediated dilatation. Hypertension. 2006;48:1088-1094.
17. Fischer D, Landmesser U, Spiekermann S, Hilfiker-Kleiner D, Hospely M, Müller M, Busse R, Fleming I, Drexler H. Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure. Eur J Heart Fail. 2007;9:770-775.
18. Joannides R, Costentin A, Iacob M, Compagnon P, Lahary A, Thuillez C. Influence of vascular dimension on gender difference in flow-dependent dilatation of peripheral conduit arteries. Am J Physiol Heart Circ Physiol. 2002;282:H1262-H1269.
19. Ambroisine ML, Favre J, Oliviero P, Rodriguez C, Gao J, Thuillez C, Samuel JL, Richard V, Delcayre C. Aldosterone-induced coronary dysfunction in transgenic mice involves the calcium-activated potassium (BKCa) channels of vascular smooth muscle cells. Circulation. 2007;116: 2435-2443.
20. Favre J, Musette P, Douin-Echinard V, Laude K, Henry JP, Arnal JF, Thuillez C, Richard V. Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2007;27:1064-1071.
21. Fleming I. Vascular cytochrome P450 enzymes: physiology and patho-physiology. Trends Cardiovasc Med. 2008;18:20-25
22. Archer SL, Gragasin FS, Wu X, Wang S, McMurtry S, Kim DH, Platonov M, Koshal A, Hashimoto K, Campbell WB, Falck JR, Michelakis ED. Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12- epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels. Circulation. 2003;107:769-776.
23. Hercule HC, Schunck WH, Gross V, Seringer J, Leung FP, Weldon SM, da Costa Goncalves ACh, Huang Y, Luft FC, Gollasch M. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice. Arterioscler Thromb Vasc Biol. 2009;29:54-60.
24. Holland M, Langton PD, Standen NB, Boyle JP. Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle. Br J Pharmacol. 1996;117:119-129.
25. Feng J, Liu Y, Clements RT, Sodha NR, Khabbaz KR, Senthilnathan V, Nishimura KK, Alper SL, Sellke FW. Calcium-activated potassium channels contribute to human coronary microvascular dysfunction after cardioplegic arrest. Circulation. 2008;118:S46-S51.
26. Popp R, Fleming I, Busse R. Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor: a modulator of arterial compliance. Circ Res. 1998;82:696-703.
27. Imig JD. Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors. Cardiovasc Drug Rev. 2006;24:169-188.
28. Loch D, Hoey A, Morisseau C, Hammock BO, Brown L. Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase. Cell Biochem Biophys. 2007;47:87-98.